Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects

Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz
Dr. Elif Yilmaz will discuss treatment options for relapsed/refractory diffuse large B-cell lymphoma patients. This presentation will include some basics of DLBCL, such as statistics, staging, and explanations of what relapse and refractory mean. Dr. Yilmaz will then discuss management options available to those with R/R DLBCL. This will include individual drugs, treatment regimens, investigational products, and supportive care.
Kat introduces the agenda of the event and featured speaker Dr. Elif Yilmaz.
Dr. Yilmaz shares information about treatment options for the relapsed/refractory DLBCL patient community.
Type your questions in the chat and Dr. Yilmaz will answer them!

Dr. Elif Yilmaz

Kat Richardson